Cost containment of pharmaceutical use in Iceland: the impact of liberalization and user charges

Samfundsvidenskab

• cost-reimbursement 100%
• cost containment 73%
• Iceland 68%
• liberalization 54%
• pharmaceutical 52%
• drug 30%
• general practitioner 24%
• social security 21%
• costs 19%
• distribution system 15%
• time series analysis 14%
• regulation 13%
• time series 11%
• health care 8%
• legislation 7%
• event 6%

Medicin og biovidenskab

• Iceland 78%
• Cost Control 70%
• Drug Costs 41%
• Costs and Cost Analysis 35%
• Interrupted Time Series Analysis 31%
• Office Visits 29%
• Social Security 28%
• Ownership 27%
• Pharmacies 26%
• Pharmaceutical Preparations 23%
• General Practitioners 20%
• Scandinavian and Nordic Countries 15%
• Legislation 12%
• Delivery of Health Care 6%